CN110108622B - Isolated microvascular endothelial barrier function detection method and device - Google Patents
Isolated microvascular endothelial barrier function detection method and device Download PDFInfo
- Publication number
- CN110108622B CN110108622B CN201910521197.6A CN201910521197A CN110108622B CN 110108622 B CN110108622 B CN 110108622B CN 201910521197 A CN201910521197 A CN 201910521197A CN 110108622 B CN110108622 B CN 110108622B
- Authority
- CN
- China
- Prior art keywords
- chamber
- vascular
- perfusion
- barrier function
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000008497 endothelial barrier function Effects 0.000 title claims abstract description 16
- 238000001514 detection method Methods 0.000 title claims abstract description 11
- 230000002792 vascular Effects 0.000 claims abstract description 40
- 239000012528 membrane Substances 0.000 claims abstract description 27
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 11
- 239000001301 oxygen Substances 0.000 claims abstract description 11
- 230000010412 perfusion Effects 0.000 claims description 37
- 239000007788 liquid Substances 0.000 claims description 18
- 230000001105 regulatory effect Effects 0.000 claims description 8
- 230000000087 stabilizing effect Effects 0.000 claims description 6
- 230000002572 peristaltic effect Effects 0.000 claims description 4
- 239000003381 stabilizer Substances 0.000 claims description 4
- 230000002262 irrigation Effects 0.000 abstract description 12
- 238000003973 irrigation Methods 0.000 abstract description 12
- 102000004169 proteins and genes Human genes 0.000 abstract description 12
- 108090000623 proteins and genes Proteins 0.000 abstract description 12
- 238000002474 experimental method Methods 0.000 abstract description 10
- 230000004888 barrier function Effects 0.000 abstract description 8
- 210000005063 microvascular endothelium Anatomy 0.000 abstract description 6
- 238000000338 in vitro Methods 0.000 abstract description 5
- 239000003550 marker Substances 0.000 abstract description 3
- 238000010171 animal model Methods 0.000 abstract description 2
- 210000004204 blood vessel Anatomy 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- 210000001519 tissue Anatomy 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 238000011160 research Methods 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 210000004088 microvessel Anatomy 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910001868 water Inorganic materials 0.000 description 5
- 102000004506 Blood Proteins Human genes 0.000 description 4
- 108010017384 Blood Proteins Proteins 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000001575 pathological effect Effects 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 210000002889 endothelial cell Anatomy 0.000 description 3
- 210000003989 endothelium vascular Anatomy 0.000 description 3
- 238000011065 in-situ storage Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 206010048554 Endothelial dysfunction Diseases 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000008694 endothelial dysfunction Effects 0.000 description 2
- 210000003038 endothelium Anatomy 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000001578 tight junction Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/08—Investigating permeability, pore-volume, or surface area of porous materials
- G01N15/0806—Details, e.g. sample holders, mounting samples for testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/08—Investigating permeability, pore-volume, or surface area of porous materials
- G01N15/082—Investigating permeability by forcing a fluid through a sample
Landscapes
- Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
An in vitro microvascular endothelial barrier function detection method and device belong to the field of basic medical experimental technology and experimental equipment. In particular to an experimental method and equipment for detecting the barrier function of the isolated microvascular endothelium of an experimental animal or human body. The invention provides an in vitro microvascular endothelial barrier function detection method and device without using virulent or fluorescent marker proteins. The invention relates to an isolated microvascular endothelial barrier function detection device, which comprises a constant temperature device and is characterized in that: the constant temperature device is internally provided with an external vascular environment chamber, a semipermeable membrane chamber is arranged in the external vascular environment chamber, two ends of the semipermeable membrane chamber are provided with a vascular irrigation inflow pipe and a vascular irrigation outflow pipe which are communicated with the outside, and the external vascular environment chamber is provided with an external vascular irrigation inflow pipe, an external vascular irrigation outflow pipe and an oxygen supply pipe.
Description
Technical Field
The invention belongs to the field of basic medical experimental technology and experimental equipment. In particular to an experimental method and equipment for detecting the barrier function of the isolated microvascular endothelium of an experimental animal or human body.
Background
In recent years, the research hot spot of circularity gradually shifts from the level of heart-large blood vessels to micro blood vessels, wherein the barrier function of the endothelium of micro blood vessels is an important research direction.
Under normal conditions, the microvascular endothelium is connected between cells by tight junction proteins and adhesion junction proteins, so that small molecular substances such as water, oxygen, carbon dioxide, glucose and the like can freely diffuse through cell membranes, and macromolecular substances such as proteins in blood plasma and tissue fluid are isolated. Under pathological conditions such as inflammation, ischemia-reperfusion and the like, tight connection between microvascular endothelium is ineffective, and substances such as protein in plasma leak into tissues through endothelium, namely microvascular endothelial barrier dysfunction.
At present, the research mode of microvascular endothelial dysfunction mainly comprises experimental techniques at both the whole animal level and the cellular level.
The experiment of the whole animal level mainly comprises the steps of injecting fluorescent marker proteins or large molecular substances such as Yi Venturi blue into an animal circulatory system, and detecting whether endothelial barrier dysfunction occurs in blood vessels by detecting the fluorescent intensity, tissue homogenate absorbance value or frozen section fluorescence and the like under a microscope.
Although the whole animal experiment is the most main research method for the barrier function of the microvascular endothelium, the whole animal experiment has more defects: because of the complex metabolic process in vivo, the physiological and pathological mechanisms of the barrier function of the microvascular endothelium are difficult to deeply study by using antagonists, activators, medicaments and the like; because of individual differences among animals, repeated experiments with more cases are needed by the whole animal method, so that the research expense and the labor capacity are increased; for experiments of real-time monitoring, only qualitative description of leakage occurrence can not provide quantitative leakage degree indexes, and for a tissue homogenate method of quantitative detection, the time-action relationship can not be known because only the endpoint condition can be detected. Meanwhile, in the two most widely used intravascular markers, the fluorescence-marked plasma protein is expensive, and the dosage of the fluorescence-marked plasma protein is huge according to the whole administration mode of the body weight, so that the experimental budget is greatly improved; while the Iwinian blue has stronger toxicity and weaker fluorescence intensity, and has adverse effects on experimental results while harming the health of experimental persons.
In addition, at the cellular level, the vascular endothelial barrier function is characterized by culturing various primary vascular endothelial cells or endothelial cell lines (strains) and examining the cell-cell tight junctions by trans-cell membrane impedance or cell-connexin fluorescent staining after formation of a continuous monolayer.
However, in the course of culture passage, the differentiation characteristics of cells gradually deteriorate, and the growth environment lacks cell polarity due to lack of induction of subendothelial matrix layer, resulting in a large difference in physiological characteristics of the cultured monolayer endothelial cells and vascular endothelium. This index only suggests the possibility of endothelial barrier dysfunction laterally, with a weaker evidence effect.
The isolated organ tissue level experiment is an important component of the functional experiment, and the isolated tissue level can well solve the defects of the whole and cell level research method while eliminating the interference of organism nerves, body fluid factors and metabolic environment and maintaining the specific structure and part of functions of the tissue. However, no technology for detecting the level of isolated tissues is available for the barrier function of the capillary endothelium.
Disclosure of Invention
The present invention is directed to the above-mentioned problems, and provides a method and apparatus for detecting the barrier function of the endothelial cells of isolated microvasculature without using highly toxic or fluorescent marker proteins.
In order to achieve the above purpose, the invention adopts the following technical scheme that the isolated microvascular endothelial barrier function detection device comprises a constant temperature device and is characterized in that: the constant temperature device is internally provided with an external vascular environment chamber, a semipermeable membrane chamber is arranged in the external vascular environment chamber, two ends of the semipermeable membrane chamber are provided with a vascular irrigation inflow pipe and a vascular irrigation outflow pipe which are communicated with the outside, and the external vascular environment chamber is provided with an external vascular irrigation inflow pipe, an external vascular irrigation outflow pipe and an oxygen supply pipe.
As a preferable scheme of the invention, the vascular perfusion tube is connected with an intravascular perfusion fluid tank with a constant temperature device through a pressure regulating buffer pump; the blood vessel perfusion outlet pipe is connected with the perfusate collecting vessel through a pressure regulating buffer pump.
As another preferable scheme of the invention, the outer chamber perfusion inflow pipe and the outer chamber perfusion outflow pipe are respectively connected with the outer chamber perfusion liquid tank and the outer chamber liquid collecting dish through the double-channel peristaltic pump.
As a third preferred scheme of the invention, the semi-permeable membrane chamber is provided with a small chamber liquid eduction tube and a pressure stabilizing tube which are connected with the outside, and the pressure stabilizing tube is connected with a small chamber internal pressure stabilizer.
The invention relates to an in-vitro microvascular endothelial barrier function detection method, which is characterized by comprising the following steps of: separating microvessels of tissue beside an animal or human body, connecting two ends of the microvessels with a vascular perfusion tube and a vascular perfusion tube respectively, establishing an intraductal flow path, and perfusing physiological perfusion liquid containing measurable high molecular substances in the microvessels; the space outside the capillary section is sealed by a semipermeable membrane chamber containing a semipermeable membrane wall, and the semipermeable membrane chamber can allow small molecular substances such as ions, glucose, dissolved oxygen in water, water molecules and the like to pass freely, but isolate high molecular substances; an open extravascular environment chamber is arranged outside the semipermeable membrane chamber, the extravascular environment chamber is filled with isotonic physiological solution containing glucose, oxygenation is carried out at the same time, and the vascular endothelial barrier function is represented by detecting the content of high molecular substances in the semipermeable membrane chamber at each time point and the high molecular substances penetrating through the wall of the micro-blood vessel.
As a preferred embodiment, the micro-intravascular perfusion uses serum or serum containing serum proteins instead of the solution, the semi-permeable membrane chamber and the extravascular environment chamber use common physiological solution without protein, and the protein content in the semi-shielded chamber is detected by protein quantification.
Further, the normal physiological solution without protein is either wilt's solution or artificial cerebrospinal fluid.
The invention has the beneficial effects that: 1. the invention adopts an in-situ in-vitro microvascular segment, and can embody the in-situ microvascular function specificity of each organ.
2. The perfusion adopts a pressure regulating buffer pump, and under the condition of experimental design requirement, the influence of different pressure conditions on the barrier function of vascular endothelium can be detected.
3. The isolated intravascular flow path and the intravascular pool environment allow the organ in-situ environment to be different from the intravascular environment under different physiological and pathological conditions, and have good verification effect.
4. The isolated blood vessel is incubated by a small amount of the antagonist, so that the channel blocking type research can be developed, conditions are provided for deep research of physiological and pathological mechanisms, and expenditure is reduced.
Drawings
Fig. 1 is a schematic structural view of the present invention.
In the drawings, a small chamber internal pressure stabilizer, a small chamber liquid eduction tube, a blood vessel external environment chamber, a semipermeable membrane chamber, a constant temperature device, an intravascular perfusion liquid tank, a pressure regulating buffer pump, a blood vessel perfusion tube, a micro blood vessel, an external chamber perfusion tube, an oxygen bottle, an oxygen supply tube, an external chamber perfusion liquid tank, a double-channel peristaltic pump, an external chamber liquid collection vessel, an external chamber perfusion outflow tube, a constant pressure tube, a perfusion liquid collection vessel and a blood vessel perfusion outflow tube are respectively arranged in the figures 1, 2, 3, 16, 17, 18, and 19.
Detailed Description
The invention relates to an isolated microvascular endothelial barrier function detection device, which comprises a constant temperature device 5 and is characterized in that: an extravascular environment chamber 3 is arranged in the constant temperature device 5, a semipermeable membrane chamber 4 is arranged in the extravascular environment chamber 3, a vascular irrigation inflow pipe 8 and a vascular irrigation outflow pipe 19 which are communicated with the outside are arranged at two ends of the semipermeable membrane chamber 4, and an extravascular irrigation inflow pipe 10, an extravascular irrigation outflow pipe 16 and an oxygen supply pipe 12 are arranged on the extravascular environment chamber 3.
As a preferable scheme of the invention, the vascular perfusion tube 8 is connected with the vascular perfusion fluid tank 6 with the constant temperature device 5 through the pressure regulating buffer pump 7; the vascular perfusion outflow pipe 19 is connected with a perfusion fluid collecting dish 18 through a pressure regulating buffer pump 7.
As another preferred embodiment of the present invention, the outer chamber perfusion tube 10 and the outer chamber perfusion tube 16 are connected to the outer chamber perfusion liquid tank 13 and the outer chamber liquid collection dish 15 respectively through a dual-channel peristaltic pump 14.
As a third preferred aspect of the present invention, the semipermeable membrane chamber 4 is provided with a cell liquid outlet pipe 2 and a pressure stabilizing pipe 17 connected to the outside, and the pressure stabilizing pipe 17 is connected to the cell internal pressure stabilizer 1.
The invention relates to an in-vitro microvascular endothelial barrier function detection method, which is characterized by comprising the following steps of: separating the tissue microvessels 9 beside the tumor of the animal or human body, respectively connecting two ends of the microvessels 9 with a vascular perfusion tube 8 and a vascular perfusion tube 19, establishing an intraductal flow path, and perfusing physiological perfusion liquid containing measurable high molecular substances in the microvessels 9; the outer space of the section 9 of the capillary is sealed by a semipermeable membrane chamber 4 containing a semipermeable membrane wall, and the semipermeable membrane chamber 4 can allow small molecular substances such as ions, glucose, dissolved oxygen in water, water molecules and the like to pass freely, but isolate high molecular substances; an extravascular environment chamber 3 which is opened is arranged outside the semipermeable membrane chamber 4, the extravascular environment chamber 3 is filled with isotonic physiological solution containing glucose, oxygenation is carried out at the same time, and the vascular endothelial barrier function is represented by detecting the content of high molecular substances in the semipermeable membrane chamber 4 at each time point and the quality of the high molecular substances penetrating through the wall of the microvascular 9.
As a preferred option, the micro-blood vessels 9 are perfused with serum or serum containing serum proteins instead of solution, the semi-permeable membrane chamber 4 and the extravascular environment chamber 3 are used with normal physiological solution without protein, and protein content in the semi-shielded cells is detected by protein quantification.
Further, the normal physiological solution without protein is either wilt's solution or artificial cerebrospinal fluid.
The oxygen supply pipe 12 is connected with an oxygen bottle 11.
Examples: animal tissue is taken, placed in a physiological solution saturated with pre-oxygen, microvessels 9 with diameters of 100-400 microns and no branches are separated under a microscope, surrounding connective tissues are carefully peeled off, the blood vessels are separated, one end of each blood vessel is ligated to an exhausted vascular perfusion tube 8 by a microsurgery line, blood in each blood vessel is carefully flushed out, the other end of each blood vessel is ligated to a vascular perfusion tube 19, and vascular perfusion liquid is injected under constant pressure. After the solution is updated, the semipermeable membrane chamber 4 is closed, the ventilation and liquid updating of the extravascular environment chamber 3 are kept, a gradient vascular flushing activation program is operated, after the completion, the solution in the semipermeable membrane chamber 4 is updated, and after the corresponding stimulation is given, the time and the leakage rate of endothelial dysfunction of the microvasculature 9 are calculated by extracting and detecting substances in the solution in the inner chamber.
It should be understood that the foregoing detailed description of the present invention is provided for illustration only and is not limited to the technical solutions described in the embodiments of the present invention, and those skilled in the art should understand that the present invention may be modified or substituted for the same technical effects; as long as the use requirement is met, the invention is within the protection scope of the invention.
Claims (1)
1. An isolated microvascular endothelial barrier function detection device comprising a thermostat (5), characterized in that: an external vascular environment chamber (3) is arranged in the constant temperature device (5), a semipermeable membrane chamber (4) is arranged in the external vascular environment chamber (3), a vascular inflow pipe (8) and a vascular outflow pipe (19) which are communicated with the outside are arranged at two ends of the semipermeable membrane chamber (4), and an external vascular inflow pipe (10), an external vascular outflow pipe (16) and an oxygen supply pipe (12) are arranged on the external vascular environment chamber (3); the vascular perfusion tube (8) is connected with an intravascular perfusion tank (6) with a constant temperature device (5) through a pressure regulating buffer pump (7); the vascular perfusion outflow pipe (19) is connected with a perfusate collecting vessel (18) through a pressure regulating buffer pump (7); the outer chamber perfusion tube (10) and the outer chamber perfusion tube (16) are respectively connected with the outer chamber perfusion liquid tank (13) and the outer chamber liquid collecting dish (15) through a double-channel peristaltic pump (14); the semi-permeable membrane chamber (4) is provided with a small chamber liquid eduction tube (2) and a pressure stabilizing tube (17) which are connected with the outside, and the pressure stabilizing tube (17) is connected with the small chamber internal pressure stabilizer (1).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910521197.6A CN110108622B (en) | 2019-06-17 | 2019-06-17 | Isolated microvascular endothelial barrier function detection method and device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910521197.6A CN110108622B (en) | 2019-06-17 | 2019-06-17 | Isolated microvascular endothelial barrier function detection method and device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN110108622A CN110108622A (en) | 2019-08-09 |
CN110108622B true CN110108622B (en) | 2024-02-02 |
Family
ID=67495230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910521197.6A Active CN110108622B (en) | 2019-06-17 | 2019-06-17 | Isolated microvascular endothelial barrier function detection method and device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110108622B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116045878B (en) * | 2023-03-07 | 2023-06-20 | 中国人民解放军军事科学院军事医学研究院 | Method for detecting vascular diameter change |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048531A1 (en) * | 1999-02-18 | 2000-08-24 | Venpro | A bifurcated biological pulmonary valved conduit |
WO2008005998A2 (en) * | 2006-07-07 | 2008-01-10 | Georgia Tech Research Corporation | Centimeter-scale, integrated diagnostics incubator for biological culturing |
CN104837982A (en) * | 2012-09-29 | 2015-08-12 | 诺荑思公司 | Microfluidic system for reproducing functional units of tissues and organs in vitro |
CN105624037A (en) * | 2014-11-06 | 2016-06-01 | 中国科学院大连化学物理研究所 | Method for establishing in-vitro blood-brain barrier model based on micro-fluidic chip |
CN210090269U (en) * | 2019-06-17 | 2020-02-18 | 辽宁中医药大学 | In vitro microvascular endothelial barrier function detection equipment |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7622298B2 (en) * | 2006-03-24 | 2009-11-24 | Norits, Inc. | Method for creating perfusable microvessel systems |
EP3110490B1 (en) * | 2013-12-12 | 2021-05-12 | Michael S. Mirizzi | Multiple chamber, expandable therapeutic agent delivery device |
-
2019
- 2019-06-17 CN CN201910521197.6A patent/CN110108622B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000048531A1 (en) * | 1999-02-18 | 2000-08-24 | Venpro | A bifurcated biological pulmonary valved conduit |
WO2008005998A2 (en) * | 2006-07-07 | 2008-01-10 | Georgia Tech Research Corporation | Centimeter-scale, integrated diagnostics incubator for biological culturing |
CN104837982A (en) * | 2012-09-29 | 2015-08-12 | 诺荑思公司 | Microfluidic system for reproducing functional units of tissues and organs in vitro |
CN105624037A (en) * | 2014-11-06 | 2016-06-01 | 中国科学院大连化学物理研究所 | Method for establishing in-vitro blood-brain barrier model based on micro-fluidic chip |
CN210090269U (en) * | 2019-06-17 | 2020-02-18 | 辽宁中医药大学 | In vitro microvascular endothelial barrier function detection equipment |
Non-Patent Citations (2)
Title |
---|
Electrical method for detection of endothelial cell shape change in real time: Assessment of endothelial barrier function;CHINNASWAMY TIRUPPATHI;《Proc. Nati. Acad. Sci. USA》;第89卷;7919-7923 * |
外周血中血脑屏障损伤新型标记物脑微血管内皮细胞检测方法的建立;李妍;《南方医科大学学报》;第34卷(第12期);1733-1737 * |
Also Published As
Publication number | Publication date |
---|---|
CN110108622A (en) | 2019-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0138833B1 (en) | Cell viability assay methods and apparatus | |
CN1109749C (en) | Pressure-mediated intracellular delivery of molecules or microparticles | |
JP6004442B2 (en) | Circulation system | |
US20200032186A1 (en) | Fluidic chip for cell culture use, culture vessel, and culture method | |
CN107955783B (en) | Method for constructing in-vitro diabetic glomerulus model based on microfluidic chip | |
JPH0233354B2 (en) | ||
CN210090269U (en) | In vitro microvascular endothelial barrier function detection equipment | |
CN110055176B (en) | Micro-fluidic chip constructed by bionic lung cancer brain metastasis model and model construction method | |
CN209546716U (en) | A kind of toy organ room temperature machine perfusion system | |
CN110108622B (en) | Isolated microvascular endothelial barrier function detection method and device | |
Ghanem et al. | The Physiological Proof that Starling’s Law for the Capillary-Interstitial Fluid Transfer is wrong: Advancing the Porous Orifice (G) Tube Phenomenon as Replacement | |
US20110014597A1 (en) | Perfusable Bioreactor for the Production and/or Cultivation of a Human or Animal Blood Vessel and/or a Human or Animal Tissue | |
Gowers et al. | An improved rapid sampling microdialysis system for human and porcine organ monitoring in a hospital setting | |
US7435587B2 (en) | Apparatus for growing cells under variable hydrostatic pressures | |
CN106455540A (en) | Product and method for cell preservation | |
CN104560715A (en) | Method for cultivating and detecting lung cancer cells based on micro-fluidic chip | |
JP3726188B2 (en) | Apparatus with hollow fiber and method of using the same | |
CN109486679A (en) | A kind of evaluation and test of extracorporeal blood vessel bracket micro-fluidic chip and application | |
CN114480122A (en) | Establishment method and application of blood brain barrier and brain glioma co-culture model based on micro-fluidic chip | |
CN213099890U (en) | Normal-temperature mechanical preservation and re-irrigation system for rat kidney | |
CN109682586B (en) | Method for evaluating and testing in vitro intravascular stent based on microfluidic chip and application | |
CN210186175U (en) | Needle and system are kept somewhere to sustainable fluid infusion and vein of sampling based on microdialysis | |
CN209778896U (en) | Micro-fluidic chip for evaluating in vitro intravascular stent | |
CN214032524U (en) | High-density culture system for mammalian cells | |
CN219291448U (en) | Liver and islet quasi-in-vivo perfusion system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |